140 related articles for article (PubMed ID: 11866205)
1. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma.
Kysela B; Siracký J; Redecha M; Bárdos A
Neoplasma; 1990; 37(5):489-95. PubMed ID: 2234210
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.
Punnonen R; Mattila J; Kuoppala T; Koivula T
J Cancer Res Clin Oncol; 1993; 119(7):426-9. PubMed ID: 8491764
[TBL] [Abstract][Full Text] [Related]
4. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma].
Zhou XR; Du XG
Zhonghua Fu Chan Ke Za Zhi; 1992 Sep; 27(5):278-80, 316. PubMed ID: 1298588
[TBL] [Abstract][Full Text] [Related]
5. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
Takahashi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
Lindahl B; Alm P; Killander D; Långström E; Tropé C
Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
[TBL] [Abstract][Full Text] [Related]
9. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
10. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia.
Michael H; Kotylo PK; Mohr M; Roth LM
Am J Clin Pathol; 1996 Jul; 106(1):22-8. PubMed ID: 8701927
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
Lindahl B; Willén R
Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
[TBL] [Abstract][Full Text] [Related]
13. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
14. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.
Henderson GS; Brown KA; Perkins SL; Abbott TM; Clayton F
Mod Pathol; 1996 Apr; 9(4):430-8. PubMed ID: 8729985
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
19. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.
Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A
Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693
[TBL] [Abstract][Full Text] [Related]
20. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
